Filed: 2/10/2026ACC: 0001766721-26-000001
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $478.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$478.92M
Total AUM (reported)
13.81M
Total Shares
Allocation by class
COM$459.40M95.9%
COM NEW$10.99M2.3%
SPONSORED ADS$8.27M1.7%
COM CL A$257.0K0.1%
Portfolio Concentration
Top 3$440.06M91.9%
4–10$36.81M7.7%
11–25$2.05M0.4%
Top 3 weight
91.9%
Top 10 weight
99.6%
Voting Authority Distribution
Total shares with voting rights: 13.81M
Sole
Full voting authority
13.81M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares5.09M
TypeSH
Market value$389.30M
81.29%
Sole
5.09M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.32M
TypeSH
Market value$27.67M
5.78%
Sole
1.32M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$23.09M
4.82%
Sole
1.47M
Shared
0.00
None
0.00
Bicara Therapeutics Inc. (BCAX)
SOLEShares568.92K
TypeSH
Market value$9.57M
2.00%
Sole
568.92K
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares1.20M
TypeSH
Market value$8.27M
1.73%
Sole
1.20M
Shared
0.00
None
0.00
BridgeBio Oncology Therapeutics (BBOT)
SOLEShares564.63K
TypeSH
Market value$7.07M
1.48%
Sole
564.63K
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$3.43M
0.72%
Sole
521.11K
Shared
0.00
None
0.00
Scholar Rock Holding Corporation (SRRK)
SOLEShares77.03K
TypeSH
Market value$3.39M
0.71%
Sole
77.03K
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares2.05M
TypeSH
Market value$2.54M
0.53%
Sole
2.05M
Shared
0.00
None
0.00
Urogen Pharma Ltd. (URGN)
SOLEShares108K
TypeSH
Market value$2.53M
0.53%
Sole
108K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$1.31M
0.27%
Sole
434.45K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares325.37K
TypeSH
Market value$484.8K
0.10%
Sole
325.37K
Shared
0.00
None
0.00
OnKure Therapeutics, Inc. (OKUR)
SOLEShares88.61K
TypeSH
Market value$257.0K
0.05%
Sole
88.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 5.09M | SH | $389.30M 81.29% | 5.09M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.32M | SH | $27.67M 5.78% | 1.32M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $23.09M 4.82% | 1.47M | 0.00 | 0.00 |
Bicara Therapeutics Inc. (BCAX)SOLE | COM | 568.92K | SH | $9.57M 2.00% | 568.92K | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 1.20M | SH | $8.27M 1.73% | 1.20M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics (BBOT)SOLE | COM NEW | 564.63K | SH | $7.07M 1.48% | 564.63K | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM NEW | 521.11K | SH | $3.43M 0.72% | 521.11K | 0.00 | 0.00 |
Scholar Rock Holding Corporation (SRRK)SOLE | COM | 77.03K | SH | $3.39M 0.71% | 77.03K | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 2.05M | SH | $2.54M 0.53% | 2.05M | 0.00 | 0.00 |
Urogen Pharma Ltd. (URGN)SOLE | COM | 108K | SH | $2.53M 0.53% | 108K | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $1.31M 0.27% | 434.45K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 325.37K | SH | $484.8K 0.10% | 325.37K | 0.00 | 0.00 |
OnKure Therapeutics, Inc. (OKUR)SOLE | COM CL A | 88.61K | SH | $257.0K 0.05% | 88.61K | 0.00 | 0.00 |